
Increased Risk of Malignancy With Adalimumab Combination Therapy, Compared With Monotherapy, for Crohn's Disease
Keywords: فاکتور نکروز تومور; Inflammatory Bowel Disease; Anti-Tumor Necrosis Factor; Thiopurine; SEER; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CESAME; Cancers Et Surrisque Associé aux Maladies inflammatoires intestinales En France; CI; confidence interval; IBD; in